Furthermore, and for the same reasons, we speculate that ATPase inhibitors, acetylcholine receptor antagonists, and/or VEGFR inhibitors may be more effective treatment options for etoposide-resistant RB. This evidence concerns the gene DNAH8 and retinoblastoma.